The Tuberculosis Drug Accelerator at year 10 what have we learned?

Bree B. Aldridge; David Barros-Aguirre; Clifton E. Barry; Robert H. Bates; Steven J. Berthel; Helena I. Boshoff; Kelly Chibale; Xin Jie Chu; Christopher B. Cooper; Véronique Dartois; Ken Duncan; Nader Fotouhi; Fabian Gusovsky; Philip A. Hipskind; Dale J. Kempf; Joël Lelièvre; Anne J. Lenaerts; Case W. McNamara; Valerie Mizrahi; Carl Nathan; David B. Olsen; Tanya Parish; H. Michael Petrassi; Alexander Pym; Kyu Y. Rhee; Gregory T. Robertson; Jeremy Michael Rock; Eric J. Rubin; Betsy Russell; David G. Russell; James C. Sacchettini; Dirk Schnappinger; Michael Schrimpf; Anna M. Upton; Peter Warner; Paul Graham Wyatt; Ying Yuan

doi:10.1038/s41591-021-01442-2

The Tuberculosis Drug Accelerator at year 10 what have we learned?

Bree B. Aldridge
, David Barros-Aguirre
, Clifton E. Barry
, Robert H. Bates
, Steven J. Berthel
, Helena I. Boshoff
, Kelly Chibale
, Xin Jie Chu
, Christopher B. Cooper
, Véronique Dartois
, Ken Duncan
, Nader Fotouhi
, Fabian Gusovsky
, Philip A. Hipskind
, Dale J. Kempf
, Joël Lelièvre
, Anne J. Lenaerts
, Case W. McNamara
, Valerie Mizrahi
, Carl Nathan

David B. Olsen, Tanya Parish, H. Michael Petrassi, Alexander Pym, Kyu Y. Rhee, Gregory T. Robertson, Jeremy Michael Rock, Eric J. Rubin, Betsy Russell, David G. Russell, James C. Sacchettini, Dirk Schnappinger, Michael Schrimpf, Anna M. Upton, Peter Warner, Paul Graham Wyatt, Ying Yuan

Tufts University
GlaxoSmithKline
National Institutes of Health
Panorama Global
University of Cape Town
Global Health Drug Discovery Institute
Global Alliance for TB Drug Development
Hackensack Meridian Health
Gates Foundation
Eisai Co., Ltd.
Lgenia Inc.
AbbVie
Colorado State University
Scripps Research Institute
Cornell University
Merck
Seattle Children's Research Institute
Janssen-Cilag UK
Rockefeller University
Harvard University
Bill & Melinda Gates Medical Research Institute
Texas A&M University
Evotec ID
University of Dundee

Research output: Contribution to journal › Comment/debate

52 Citations (Scopus)

Original language	English
Pages (from-to)	1333-1337
Number of pages	5
Journal	Nature Medicine
Volume	27
Issue number	8
DOIs	https://doi.org/10.1038/s41591-021-01442-2
Publication status	Published - 5 Jul 2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/s41591-021-01442-2

Cite this

Aldridge, B. B., Barros-Aguirre, D., Barry, C. E., Bates, R. H., Berthel, S. J., Boshoff, H. I., Chibale, K., Chu, X. J., Cooper, C. B., Dartois, V., Duncan, K., Fotouhi, N., Gusovsky, F., Hipskind, P. A., Kempf, D. J., Lelièvre, J., Lenaerts, A. J., McNamara, C. W., Mizrahi, V., ... Yuan, Y. (2021). The Tuberculosis Drug Accelerator at year 10 what have we learned? Nature Medicine, 27(8), 1333-1337. https://doi.org/10.1038/s41591-021-01442-2

@article{0d451f762cab44d5bca26350b62bfacd,

title = "The Tuberculosis Drug Accelerator at year 10 what have we learned?",

author = "Aldridge, \{Bree B.\} and David Barros-Aguirre and Barry, \{Clifton E.\} and Bates, \{Robert H.\} and Berthel, \{Steven J.\} and Boshoff, \{Helena I.\} and Kelly Chibale and Chu, \{Xin Jie\} and Cooper, \{Christopher B.\} and V{\'e}ronique Dartois and Ken Duncan and Nader Fotouhi and Fabian Gusovsky and Hipskind, \{Philip A.\} and Kempf, \{Dale J.\} and Jo{\"e}l Leli{\`e}vre and Lenaerts, \{Anne J.\} and McNamara, \{Case W.\} and Valerie Mizrahi and Carl Nathan and Olsen, \{David B.\} and Tanya Parish and Petrassi, \{H. Michael\} and Alexander Pym and Rhee, \{Kyu Y.\} and Robertson, \{Gregory T.\} and Rock, \{Jeremy Michael\} and Rubin, \{Eric J.\} and Betsy Russell and Russell, \{David G.\} and Sacchettini, \{James C.\} and Dirk Schnappinger and Michael Schrimpf and Upton, \{Anna M.\} and Peter Warner and Wyatt, \{Paul Graham\} and Ying Yuan",

year = "2021",

month = jul,

day = "5",

doi = "10.1038/s41591-021-01442-2",

language = "English",

volume = "27",

pages = "1333--1337",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Research",

number = "8",

}

Aldridge, BB, Barros-Aguirre, D, Barry, CE, Bates, RH, Berthel, SJ, Boshoff, HI, Chibale, K, Chu, XJ, Cooper, CB, Dartois, V, Duncan, K, Fotouhi, N, Gusovsky, F, Hipskind, PA, Kempf, DJ, Lelièvre, J, Lenaerts, AJ, McNamara, CW, Mizrahi, V, Nathan, C, Olsen, DB, Parish, T, Petrassi, HM, Pym, A, Rhee, KY, Robertson, GT, Rock, JM, Rubin, EJ, Russell, B, Russell, DG, Sacchettini, JC, Schnappinger, D, Schrimpf, M, Upton, AM, Warner, P, Wyatt, PG & Yuan, Y 2021, 'The Tuberculosis Drug Accelerator at year 10 what have we learned?', Nature Medicine, vol. 27, no. 8, pp. 1333-1337. https://doi.org/10.1038/s41591-021-01442-2